Eterna Skin

Eterna is a biotechnology company focused on the intersection of regenerative medicine and skin health. The company utilizes proprietary mRNA and lipid nanoparticle (LNP) delivery technologies to develop treatments that aim to reverse the biological signs of skin aging and promote tissue regeneration. By delivering specific genetic instructions directly to skin cells, Eterna's platform seeks to restore the production of essential proteins like collagen and elastin. The company's approach represents a shift from traditional topical skincare to advanced genetic therapies for dermatological applications. Eterna was part of the Y Combinator Winter 2022 cohort and is headquartered in San Francisco. Its research focuses on leveraging the body's natural regenerative capabilities to address age-related skin degradation and photoaging.